Arpit Gupta

Arpit Gupta

Auto-generated profile, based on publicly available information

Arpit Gupta

Division of Chemistry and Chemical Engineering California Institute of Technology Pasadena California USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2023 in Science Advances
Verified
Journal Article
Open access
AGArpit Gupta
Arpit Gupta
ALAlfred M. Lentzsch
Alfred M. Lentzsch
ASAlex Siegel
Alex Siegel
ZYZanlin Yu
Zanlin Yu
UCUn Seng Chio
Un Seng Chio
SSShu-ou Shan
Shu-ou Shan
Ring-forming AAA + chaperones solubilize protein aggregates and protect organisms from proteostatic stress. In metazoans, the AAA + chaperone Skd3 in the mitochondrial intermembrane space (IMS) is critical for human health and efficiently refolds aggregated proteins, but its underlying mechanism is poorly understood. Here, we show that Skd3 harbors both disaggregase and protein refolding activities enabled by distinct assembly states. High-resolution structures of Skd3 hexamers in distinct conformations capture ratchet-like motions that mediate substrate extraction. Unlike previously described disaggregases, Skd3 hexamers further assemble into dodecameric cages in which solubilized substrate proteins can attain near-native states. Skd3 mutants defective in dodecamer assembly retain disaggregase activity but are impaired in client refolding, linking the disaggregase and refolding activities to the hexameric and dodecameric states of Skd3, respectively. We suggest that Skd3 is a combined disaggregase and foldase, and this property is particularly suited to meet the complex proteostatic demands in the mitochondrial IMS.

10 November 2022 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MPMitra Pirhaghi
Mitra Pirhaghi
SFSigne Andrea Frank
Signe Andrea Frank
PAParvez Alam
Parvez Alam
JNJanni Nielsen
Janni Nielsen
VSVita Sereikaite
Vita Sereikaite
DODaniel Otzen
Daniel Otzen
Parkinson's disease is a neurodegenerative movement disorder associated with the intracellular aggregation of α-synuclein (α-syn). Cytotoxicity is mainly associated with the oligomeric species (αSOs) formed at early stages in α-syn aggregation. Consequently, there is an intense focus on the discovery of novel inhibitors such as peptides to inhibit oligomer formation and toxicity. Here, using peptide arrays, we identified nine peptides with high specificity and affinity for αSOs. Of these, peptides p194, p235, and p249 diverted α-syn aggregation from fibrils to amorphous aggregates with reduced β-structures and increased random coil content. However, they did not reduce αSO cytotoxicity and permeabilization of large anionic unilamellar vesicles. In parallel, we identified a non–self-aggregating peptide (p216), derived from the cell-penetrating peptide penetratin, which showed 12-fold higher binding affinity to αSOs than to α-syn monomers (Kdapp 2.7 and 31.2 μM, respectively). p216 reduced αSOs-induced large anionic unilamellar vesicle membrane permeability at 10−1 to 10−3 mg/ml by almost 100%, was not toxic to SH-SY5Y cells, and reduced αSOs cytotoxicity by about 20%. We conclude that p216 is a promising starting point from which to develop peptides targeting toxic αSOs in Parkinson's disease.

25 July 2023 in Protein Science
Verified
Journal Article
Closed access
AGArpit Gupta
Arpit Gupta
CLChuqi Lu
Chuqi Lu
FWFeng Wang
Feng Wang
TCTsui‐Fen Chou
Tsui‐Fen Chou
SSShu-ou Shan
Shu-ou Shan